Ocean Bio-Chem
OBCI
OBCI was delisted on the 8th of August, 2022.
8 hedge funds and large institutions have $292K invested in Ocean Bio-Chem in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0.03% more ownership
Funds ownership: 1.21% → 1.24% (+0.03%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
2% less capital inflows, than outflows
Capital inflows: $74.7K | Capital outflows: $76.1K
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$72.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thompson Davis & Co
Richmond,
Virginia
|
-$71K |
| 2 |
Tower Research Capital (TRC)
New York
|
-$5.07K |
OBCI Hedge Fund Activity: Q3 2015 in Review
8 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Ocean Bio-Chem (OBCI) for Q3 2015, worth a combined $292K — down 24% from $385K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of OBCI and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Shepherd Kaplan Krochuk, opening a new position worth an estimated $72.5K. The largest seller was Thompson Davis & Co, exiting entirely with an estimated $71K sold.
- 8 institutional investors held Ocean Bio-Chem (OBCI) as of Q3 2015, down from 10 in Q2 2015.
- Funds reported $292K of Ocean Bio-Chem stock for Q3 2015, down 24% quarter-over-quarter.
- 1 fund opened new Ocean Bio-Chem positions in Q3 2015 and 3 closed out, a net change of -2 holders.
- The largest Ocean Bio-Chem buyer in Q3 2015 was Shepherd Kaplan Krochuk, an estimated $72.5K added.
- The largest Ocean Bio-Chem seller in Q3 2015 was Thompson Davis & Co, an estimated $71K sold.
Based on aggregated 13F filings for Q3 2015.